Bio-Gene Technology Limited Price (BGT.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

185,817,655

(10.7585)%

Bio-Gene Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.028-0.085
  • Market Cap 6.04M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Timothy Owen Grogan B.Sc., LLB
  • IPO Date: November, 28, 2017
  • Country: AU
  • Currency: AUD
  • Headquaters: Melbourne, VIC
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation